Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 3.38
(0.9%)
CNY 3.38
(0.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.81 Billion CNY | -14.56% |
| 2022 | 2.99 Billion CNY | -9.46% |
| 2021 | 3.3 Billion CNY | 16.35% |
| 2020 | 2.83 Billion CNY | 3.64% |
| 2019 | 2.73 Billion CNY | 15.39% |
| 2018 | 2.37 Billion CNY | 33.67% |
| 2017 | 1.77 Billion CNY | -17.79% |
| 2016 | 2.16 Billion CNY | -0.47% |
| 2015 | 2.17 Billion CNY | 14.38% |
| 2014 | 1.89 Billion CNY | 37.92% |
| 2013 | 1.37 Billion CNY | 106.02% |
| 2012 | 667.8 Million CNY | 200.81% |
| 2011 | 222 Million CNY | 55.91% |
| 2010 | 142.39 Million CNY | 66.42% |
| 2009 | 85.56 Million CNY | 33.7% |
| 2008 | 63.99 Million CNY | 51.6% |
| 2007 | 42.21 Million CNY | 67.39% |
| 2006 | 25.21 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 669.23 Million CNY | 1.29% |
| 2024 Q2 | 686.3 Million CNY | 4.73% |
| 2024 Q1 | 655.31 Million CNY | 12.06% |
| 2023 Q3 | 585.8 Million CNY | -25.19% |
| 2023 FY | 2.55 Billion CNY | -14.56% |
| 2023 Q1 | 739.94 Million CNY | -16.55% |
| 2023 Q2 | 783.1 Million CNY | 5.83% |
| 2023 Q4 | 584.8 Million CNY | -0.17% |
| 2022 Q2 | 680.25 Million CNY | 2.09% |
| 2022 Q1 | 666.31 Million CNY | -40.72% |
| 2022 Q3 | 757.03 Million CNY | 11.29% |
| 2022 FY | 2.99 Billion CNY | -9.46% |
| 2022 Q4 | 886.64 Million CNY | 17.12% |
| 2021 Q4 | 1.12 Billion CNY | 38.31% |
| 2021 Q3 | 812.71 Million CNY | 15.86% |
| 2021 Q1 | 664.33 Million CNY | -20.15% |
| 2021 Q2 | 701.43 Million CNY | 5.58% |
| 2021 FY | 3.3 Billion CNY | 16.35% |
| 2020 Q1 | 536.74 Million CNY | -36.57% |
| 2020 Q3 | 818.16 Million CNY | 25.66% |
| 2020 Q4 | 831.93 Million CNY | 1.68% |
| 2020 FY | 2.83 Billion CNY | 3.64% |
| 2020 Q2 | 651.07 Million CNY | 21.3% |
| 2019 Q1 | 532.42 Million CNY | -31.64% |
| 2019 Q4 | 846.24 Million CNY | 21.18% |
| 2019 Q3 | 698.34 Million CNY | 5.9% |
| 2019 Q2 | 659.43 Million CNY | 23.86% |
| 2019 FY | 2.73 Billion CNY | 15.39% |
| 2018 Q2 | 496.52 Million CNY | 2.91% |
| 2018 FY | 2.37 Billion CNY | 33.67% |
| 2018 Q4 | 778.9 Million CNY | 27.09% |
| 2018 Q3 | 612.88 Million CNY | 23.44% |
| 2018 Q1 | 482.49 Million CNY | -21.15% |
| 2017 FY | 1.77 Billion CNY | -17.79% |
| 2017 Q1 | 363.94 Million CNY | -43.11% |
| 2017 Q2 | 309.36 Million CNY | -15.0% |
| 2017 Q4 | 611.93 Million CNY | 24.72% |
| 2017 Q3 | 490.62 Million CNY | 58.59% |
| 2016 Q3 | 551.33 Million CNY | 13.65% |
| 2016 FY | 2.16 Billion CNY | -0.47% |
| 2016 Q4 | 639.77 Million CNY | 16.04% |
| 2016 Q2 | 485.1 Million CNY | 0.25% |
| 2016 Q1 | 483.87 Million CNY | -31.88% |
| 2015 Q3 | 546.24 Million CNY | 5.41% |
| 2015 FY | 2.17 Billion CNY | 14.38% |
| 2015 Q2 | 518.23 Million CNY | 31.01% |
| 2015 Q1 | 395.58 Million CNY | -30.86% |
| 2015 Q4 | 710.32 Million CNY | 30.04% |
| 2014 Q4 | 572.1 Million CNY | 11.66% |
| 2014 Q2 | 481.28 Million CNY | 45.09% |
| 2014 Q1 | 331.71 Million CNY | -28.97% |
| 2014 FY | 1.89 Billion CNY | 37.92% |
| 2014 Q3 | 512.35 Million CNY | 6.46% |
| 2013 FY | 1.37 Billion CNY | 106.02% |
| 2013 Q4 | 467.01 Million CNY | 48.42% |
| 2013 Q1 | 261.66 Million CNY | -10.33% |
| 2013 Q2 | 332.46 Million CNY | 27.06% |
| 2013 Q3 | 314.66 Million CNY | -5.35% |
| 2012 Q4 | 291.8 Million CNY | 60.63% |
| 2012 Q2 | 139.06 Million CNY | 151.64% |
| 2012 Q1 | 55.26 Million CNY | -38.23% |
| 2012 FY | 667.8 Million CNY | 200.81% |
| 2012 Q3 | 181.66 Million CNY | 30.63% |
| 2011 Q2 | 45.19 Million CNY | 20.18% |
| 2011 Q4 | 89.46 Million CNY | 79.86% |
| 2011 FY | 222 Million CNY | 55.91% |
| 2011 Q1 | 37.6 Million CNY | -43.77% |
| 2011 Q3 | 49.74 Million CNY | 10.06% |
| 2010 Q2 | 25.56 Million CNY | 63.25% |
| 2010 Q4 | 66.87 Million CNY | 95.02% |
| 2010 Q3 | 34.29 Million CNY | 34.13% |
| 2010 Q1 | 15.66 Million CNY | -58.22% |
| 2010 FY | 142.39 Million CNY | 66.42% |
| 2009 Q2 | 16.44 Million CNY | 15.03% |
| 2009 Q1 | 14.29 Million CNY | -51.88% |
| 2009 FY | 85.56 Million CNY | 33.7% |
| 2009 Q4 | 37.48 Million CNY | 116.34% |
| 2009 Q3 | 17.32 Million CNY | 5.36% |
| 2008 Q3 | 13.41 Million CNY | 0.0% |
| 2008 FY | 63.99 Million CNY | 51.6% |
| 2008 Q4 | 29.71 Million CNY | 121.43% |
| 2007 FY | 42.21 Million CNY | 67.39% |
| 2006 FY | 25.21 Million CNY | 0.0% |